Dr. Mandira Ray, MD

  • Auburndale, MA
  • Hematologist and oncologist
NPI1659338606PAC ID9931112927
Medicare services, 2024
17,756
Medicare patients, 2024
352
Part D claims, 2024
973
Publications
1
Hospital affiliations
2
Practice address
275 Grove St, Auburndale, MA 02466
Practice phone
Call (617) 421-1000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Atrius Health, Inc.

Auburndale, Massachusetts

See all 5 affiliations

Find Dr. Ray's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mandira Ray is a hematologist and oncologist in Auburndale, Massachusetts

Dr. Ray practices at Atrius Health, Inc. in Auburndale, Massachusetts.

Dr. Ray's NPI, 1659338606, was assigned on April 26, 2006. Dr. Ray holds Massachusetts license 226763.

NPI and contact details
Medicare PAC ID
9931112927
NPI enumeration date
April 26, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(617) 421-1000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
49
Medical school graduation
2003

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mandira Ray practices at Atrius Health, Inc. in Auburndale, Massachusetts

Dr. Ray's primary practice is Atrius Health, Inc., at 275 Grove St, Auburndale, MA 02466 in Middlesex County. The practice phone is (617) 421-1000.

  • Atrius Health, Inc.
    275 Grove St, Auburndale, MA 02466 · Middlesex CountyPhone(617) 421-1000

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Mandira Ray is affiliated with 4 sites of care and 1 medical group

Dr. Ray's primary practice is Atrius Health, Inc. in Auburndale, Massachusetts. Dr. Ray is also affiliated with Beth Israel Deaconess Medical Center. The medical group on file is Atrius Health. Dmand AI also links Dr. Ray to 1 more hospital and 1 group practice or clinic, each named with a free account.

See all 5 affiliations for Dr. Ray

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Mandira Ray's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ray practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Atrius Health, Inc.Available with a free account
+3 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Ray practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mandira Ray is one of 429 hematologists and oncologists in Massachusetts

Hematology and oncology is Dr. Ray's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ray is licensed in Massachusetts.

Specialties and state licenses

  • Hematology and oncology, MassachusettsPrimaryLicense 226763 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Ray

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

429hematologists and oncologists in Massachusetts
3hematologists and oncologists in Auburndale

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mandira Ray billed Medicare for 17,756 services in 2024

CMS data shows 17,756 Medicare services from Dr. Ray across 44 procedure codes in 2024, for 352 Medicare patients. Medicare paid $178,701 for them. Every service was in an office.

Medicare services, 202417,756
Medicare patients352
Paid by Medicare$178,701
Procedure codes44

Dr. Ray's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Other services
2023: 172024: 11,27366212%
Lab and pathology
2023: 3,2602024: 3,96122%
Surgery
2023: 9392024: 1,05312%
Office and hospital visits
2023: 6772024: 7145%
Tests and treatments
2023: 3882024: 46520%
Drugs given in the office
2023: 4212024: 29031%

Dr. Ray compared with the Massachusetts median for hematologists and oncologists, 2024

  • Dr. Ray
  • Massachusetts median
Medicare services
17,756vs 49535.9 times
Medicare patients
352vs 20076% above
Part D claims
772vs 1515.1 times

Medians across 415 hematologists and oncologists in Massachusetts with Dmand AI profiles that report each measure.

Dr. Ray's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Ray

Need commercial claims for Dr. Ray?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Ray and other hematologists and oncologists in Massachusetts.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mandira Ray treated 352 Medicare patients in 2024, average age 75

CMS counts 352 Medicare patients who saw Dr. Ray in 2024. The largest group is 65 to 74, with 150 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ray's median patient age at 70, with 53% women.

Medicare patients, 2024352
Average age75
Average risk score1.80
Also on Medicaid9%

Dr. Ray's Medicare patients by age, 2024

Dr. Ray's Medicare patients by sex, 2024

  • Women17048%
  • Men18252%

Chronic conditions among Dr. Ray's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure74%
  3. Arthritis38%
  4. Cancer38%
  5. Chronic kidney disease36%
  6. Diabetes34%
  7. Ischemic heart disease30%
  8. Mood disorders26%

Share of Medicare patients with each condition. A patient can have several.

Dr. Ray's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women53%
  • Men46%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mandira Ray wrote 973 Medicare Part D claims in 2024

In 2024, Dr. Ray wrote 973 Medicare Part D claims for 143 patients. 68% of them were for generic drugs. CMS names the drug for 772 of them, across 21 drugs with 11 or more claims each, at $4,595,396 in total drug cost. In 2023, CMS named 915 claims across 26 drugs.

Part D claims, 2024973
Drugs named by CMS21
Total drug cost$4.6M
Part D patients143

Dr. Ray's Part D claims by kind of drug, 2024

  • Generic661 claims68%
  • Brand-name312 claims32%

Dr. Ray's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Ray's Part D claims, 2024

  • Opioids2%23 of 973 claims
  • Antibiotics4%40 of 973 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 9152024: 77216%

Drugs named by CMS: 21 in 2024, 26 in 2023.

See all prescribing by Dr. Ray

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Mandira Ray offers telehealth to Medicare patients

Dr. Ray accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ray as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Ray by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mandira Ray has 1 publication on record

Dmand AI links 1 paper to Dr. Ray in 2016. Dr. Ray's most frequent co-authors are Christopher K. Daugherty, Blase N. Polite and David Gary Smith, MD.

Papers1

Dr. Ray's most frequent co-authors

Recent publications by Dr. Ray

See all 1 publications and co-authors

See who Dr. Ray researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Ray works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Mandira Ray received $221 in industry payments from 2019 to 2022

CMS Open Payments shows 5 general payments to Dr. Ray from 3 drug and device companies from 2019 to 2022. Food and beverage make up the largest share, 94% of the total. Bard Access Systems, Inc. paid the most, $186.

General payments to Dr. Ray by program year, 2019 to 2022

General payments to Dr. Ray by kind, 2019 to 2022

$221in total
  • Food and beverage$20894%
  • Education$136%

Companies that paid Dr. Ray the most, 2019 to 2022

Share is of all general payments to this clinician.

See all payments to Dr. Ray

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Mandira Ray's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mandira Ray

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mandira Ray's NPI number?

Dr. Mandira Ray's NPI number is 1659338606. It was assigned on April 26, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Mandira Ray?

Dr. Mandira Ray is a hematologist and oncologist in Auburndale, Massachusetts. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Mandira Ray practice?

Dr. Ray practices at 275 Grove St, Auburndale, MA 02466. Dr. Ray's primary practice is Atrius Health, Inc. in Auburndale, Massachusetts. Dmand AI also links Dr. Ray to 1 hospital and 1 group practice or clinic.

What is Dr. Mandira Ray's office phone number?

The practice phone on file for Dr. Ray is (617) 421-1000.

What is Dr. Mandira Ray's medical license number?

Dr. Ray holds Massachusetts license 226763.

Which hospitals is Dr. Mandira Ray affiliated with?

Dr. Ray is affiliated with Beth Israel Deaconess Medical Center. Dmand AI links Dr. Ray to 1 more hospital.

What medical group is Dr. Mandira Ray part of?

Dr. Ray is linked to Atrius Health.

Does Dr. Mandira Ray accept Medicare?

Yes. CMS data shows Dr. Ray billed Medicare for 17,756 services in 2024, and Dr. Ray accepts Medicare assignment.

Does Dr. Mandira Ray offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Ray as offering telehealth services.

How many Medicare patients does Dr. Mandira Ray see?

CMS counts 352 Medicare patients who saw Dr. Ray in 2024, with an average age of 75.

Show 6 more questionsShow fewer questions

What services does Dr. Mandira Ray bill to Medicare?

In 2024, Dr. Ray's most billed Medicare services were medicare temporary code (Q0138), surgery: heart and blood vessels (36415) and lab and pathology test (85025).

What drugs does Dr. Mandira Ray prescribe most?

In 2024 Medicare Part D data, Dr. Ray's most prescribed drugs by claims were Hydroxyurea, Lenalidomide and Abiraterone Acetate.

Has Dr. Mandira Ray received payments from drug or device companies?

CMS Open Payments shows $221 in general payments to Dr. Ray from 3 companies from 2019 to 2022. The largest total came from Bard Access Systems, Inc.

How long has Dr. Mandira Ray been practicing?

Dr. Ray graduated from medical school in 2003, 23 years ago.

Does Dr. Mandira Ray do research?

Dmand AI links 1 publication to Dr. Ray.

Who does Dr. Mandira Ray publish with?

Dr. Ray's most frequent co-authors are Christopher K. Daugherty (1 shared paper), Blase N. Polite (1 shared paper) and David Gary Smith, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in Massachusetts by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)